Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: Proposed mechanism of interaction

Blood

Volumn 89, Issue 4, 1997, Pages 1319-1333

  Kalai, Michael ^b   Montero Julian, Fèlix A ^b   Grötzinger, Joachim ^b   Fontaine, Véronique ^b   Vandenbussche, Paul ^b   Deschuyteneer, Rudi ^b   Wollmer, Axel ^b   Brailly, Hervé ^b   Content, Jean ^a  

^a PASTEUR INSTITUTE OF BRUSSELS   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; GENE MUTATION; HYPOTHESIS; LIVER CELL; MEMBRANE POTENTIAL; PREDICTION; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

EID: 0031043061     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1319     Document Type: Article

References (72)

1. Akira S, Taga T, Kishimoto T: Interleukin-6 in biology and medicine. Adv Immunol 54:1, 1993
2. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58:573, 1989
3. Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T: IL-6-induced homodimerization of gp-130 and associated activation of a tyrosine kinase. Science 260:1808, 1993
4. Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL, Simpson RJ: High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 269:23286, 1994
5. Paonessa G, Graziani R, De Serio A, Savino R, Ciapponi L, Lahm A, Salvati AL, Toniatti C, Ciliberto G: Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling. EMBO J 14:1942, 1995
6. Sugita T, Totsuka T, Saito M, Yamasaki K, Taga T, Hirano T, Kishimoto T: Functional murine interleukin 6 receptor with the intracisternal A particle gene product at its cytoplasmic domain: Its possible role in plasmacytomagenesis. J Exp Med 171:2001, 1990
7. Novick D, Shulman LM, Chen L, Revel M: Enhancement of interleukin-6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibody. Cytokine 4:6, 1992
8. Bazan JF: Hematopoietic receptors and helical cytokines. Immunol Today 11:350, 1990
9. Sprang RS, Bazan JF: Cytokine structural taxonomy and mechanisms of receptor engagement. Curr Opin Struct Biol 3:815, 1993
10. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934, 1990
11. Cosman D, Lyman SD, Idzerda RL, Beckmann MP, Park LS, Goodwin RG, March CJ: A new cytokine receptor superfamily. Trends Biochem Sci 15:265, 1990
12. Kishimoto T, Akira S, Narazaki M, Taga T: Interleukin-6 family of cytokines and gp130. Blood 86:1243, 1995
13. Lu C, Kerbel S: lnterleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during melanoma progression. J Cell Biol 120:1281, 1993
14. Mahieu M, Deschuyteneer R, Forget D, Vandenbussche P, Content J: Construction of a ribozyme directed against human interleukin-6 mRNA: Evaluation of its catalytic activity in vitro and in vivo. Blood 84:3758, 1994
15. Brakenhoff J, de Hon FD, Fontaine V, Tenboekel E, School-tink H, Rose-John S, Heinrich PC, Content J, Aarden LA: Development of a human interleukin-6 receptor antagonist. J Biol Chem 269:86, 1994
16. de Hon FD, Ehlers M, Rose-John S, Ebeling SB, Klaasse Bos H, Aarden LA, Brakenhoff JPJ: Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. J Exp Med 180:2395, 1994
17. Ehlers M, Grotzinger J, de Hon FD, Mullberg J, Brakenhoff J, Liu JW, Wollmer A, Rose-John S: Identification of two novel regions of human IL-6 responsible for receptor binding and signal transduction. J Immunol 153:1744, 1994
18. Savino R, Ciapponi L, Lahm A, Demartis A, Cabibbo A, Toniatti C, Delmastro P, Altamura S, Ciliberto G: Rational design of a receptor super-antagonist of human interleukin-6. EMBO J 13:5863, 1994
19. Salvati AL, Lahm A, Paonessa G, Ciliberto G, Toniatti C: Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface. J Biol Chem 270:12242, 1995
20. Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R: Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw 1:193, 1990
21. Daveau M, Liautard J, Gaillard JP, Hiron M, Brochier J, Lebreton JP: IL-6-induced changes in synthesis of alpha 1-acid glycoprotein in human hepatoma Hep3B cells are distinctively regulated by monoclonal antibodies directed against different epitopes of IL-6 receptor (gp80). Eur Cytokine Netw 5:601, 1994
22. Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay J-Y, Gabarre J, Gaillard J-P, Brochier J, Raphael M, Boue F, Galanaud P: Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: Effect on lymphoma growth and on B clinical symptoms. Blood 84:2472, 1994
23. Brochier J, Legouffe E, Liautard J, Gaillard JP, Mao LQ, Bataille R, Rossi JF, Klein B: Immunomodulating IL-6 activity by murine monoclonal antibodies. Int J Immunopharmacol 17:41, 1995
24. McDonald NQ, Panayotatos N, Hendrickson WA: Crystal structure of dimeric human ciliary neurotrophic factor determined by MAD phasing. EMBO J 14:2689, 1995
25. De Vos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306, 1992
26. Somers W, Ultsch M, De Vos AM, Kossiakoff AA: The x-ray structure of a growth hormone-prolactin receptor complex. Nature 372:478, 1994
27. Grötzinger J, Kurapkat G, Wollmer A, Kalai M, Rose-John S: The family of the IL-6-type cytokines: Specificity and promiscuity of the receptor complexes. Protein (in press)
28. Kalai M, Montero-Julian FA, Grötzinger J, Wollmer A, Morelle D, Brochier J, Rose-John S, Heinrich PC, Brailly H, Content J: Participation of two Ser-Ser-Phe-Tyr repeats in IL-6 binding sites of human interleukin-6 receptor. Eur J Biochem 238:714, 1996
29. Fontaine V, Savino R, Arcone R, De Wit L, Brakenhoff J, Content J, Ciliberto G: Involvement of the Argl79 in the active site of human IL-6. Eur J Biochem 211:749, 1993
30. Fontaine V, Ooms J, Content J: Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: Involvement of the Arg168 in the binding site. Eur J Immunol 24:1041, 1994
31. Nicholls A, Sharp KA, Honig B: Insights from the interfacial and thermodinamics properties of hydrocarbons. Proteins 11:281, 1991
32. Carson M: RIBBONS 2.0. J Appl Crystallogr 24:946, 1991
33. Fontaine V, De Wit L, Brakenhoff J, Content J: Structure function studies of human IL-6, in Oppenheim JJ, Powanda MC, Kluger MJ, Dinarello CA (eds): Molecular and Cellular Biology of Cytokines. New York, NY, Wiley-Liss, 1990, p 45
34. Fontaine V, Brakenhoff J, De Wit L, Arcone R, Ciliberto G, Content J: Internal deletions in human interleukin-6 - Structure-function analysis. Gene 104:227, 1991
35. Innis MA, Gelfand DH: Optimization of PCRs. San Diego, CA, Academic, 1990
36. Poupart P, Vandenabeele P, Cayphas S, Van Snick J, Haegeman G, Kruys V, Fiers W, Content J: B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J 6:1219, 1987
37. Brailly H, Montero-Julian FA, Zuber CE, Flavetta S, Grassi J, Houssiau F, Van Snick J: Total interleukin-6 in plasma measured by immunoassay. Clin Chem 40:116, 1994
38. Montero-Julian FA, Liautard J, Flavetta S, Romagne F, Gaillard JP, Brochier J, Klein B, Brailly H: Immunoassay for functional human soluble interleukin-6 receptor in plasma based on ligand/ receptor interactions. J Immunol Methods 169:111, 1994
39. Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ: Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83:9679, 1986
40. Jourdan M, Bataille R, Seguin J, Zhang XG, Chaptal PA, Klein B: Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. Arthritis Rheum 33:398, 1990
41. Wijdenes J, Clement C, Klein B, Morel-Fourier B, Vita N, Ferrara P, Peters A: Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. Mol Immunol 28:1183, 1991
42. Novick D, Engelmann H, Revel M, Leitner O, Rubinstein M: Monoclonal antibodies to the soluble human IL-6 receptor: Affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 10:137, 1991
43. Hill CP, Osslund TD, Eisenberg D: The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc Natl Acad Sci USA 90:5167, 1993
44. Weiegräber O, Schneider-Mergener J, Grötzinger J, Wollmer A, Küster A, Exner M, Hienrich PC: Use of immobilized synthetic peptides for the identification of contact sites between human interleukin-6 and its receptor. FEBS Lett 379:122, 1996
45. Hammacher A, Ward DL, Weinstock J, Treutlein H, Yasukawa K, Simpson RJ: Structure-function analysis of human IL-6: Identification of two distinct regions that are important for receptor binding. Protein Sci 3:2280, 1994
46. Yawata H, Yasukawa K, Natsuka S, Murakami M, Yamasaki K, Hibi M, Taga T, Kishimoto T: Structure-function analysis of human IL-6 receptor - Dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J 12:1705, 1993
47. Martin F, Toniatti C, Salvati AL, Venturini S, Ciliberto G, Cortese R, Sollazzo M: The affinity-selection of a minibody polypeptide inhibitor of human interleukin-6. EMBO J 13:5503, 1994
48. Martin F, Toniati C, Salvati AL, Ciliberto G, Cortese R, Sollazzo M: Coupling protein design and in vitro selection strategies: Improving specificity and affinity of a designed β-protein IL-6 antagonist. J Mol Biol 255:86, 1996
49. Grube BJ, Cochrane CG: Identification of a regulatory domain of the interleukin-6 receptor. J Biol Chem 269:20791, 1994
50. Savino R, Lahm A, Salvati AL, Ciapponi L, Sporeno E, Altamura S, Paonessa G, Toniatti C, Ciliberto G: Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation. EMBO J 13:1357, 1994
51. Fontaine V, Arcone A, Coto I, Brakenhoff J, Savino R, De Wit L, Ciliberto G, Content J: Identification of residues critical for biological activity and receptor binding of human interleukin 6, in Revel M (ed): IL-6 Physiopathology and Clinical Potentials. Serono Symposium on IL-6, vol 88. New York, NY, Raven, 1992, p 23
52. Fiorillo MT, Toniatti C, Van Snick J, Ciliberto G: Expression of the murine interleukin-6 receptor in hepatoma cells - The intracytoplasmic domain is not required for interleukin-6 signal transduction. Eur J Immunol 22:799, 1992
53. Clackson T, Wells JA: A hot spot of binding energy in a hormone-receptor interface. Science 267:383, 1995
54. Imler JL, Miyajima A, Zurawski G: Identification of 3 adjacent amino acids of interleukin-2 receptor beta-chain which control the affinity and the specificity of the interaction with interleukin-2. EMBO J 11:2047, 1992
55. Wang HM, Ogorochi T, Arai K, Miyajima A: Structure of mouse interleukin-3 (IL-3) binding protein (AIC2A) - Amino acid residues critical for IL-3 binding. J Biol Chem 267:979, 1992
56. Woodcock JM, Zacharakis B, Plaetink G, Bagley CJ, Qiyu S, Hercus TR, Tavernier J, Lopez AF: Three residues in the common β chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF. EMBO J 13:5176, 1994
57. Gearing DP, Cosman D: Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 66:9, 1991
58. Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK, Gubler U: Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol 153:128, 1994
59. Hilton DJ, Hilton AA, Raicevic A, Rakar S, Harrisonsmith M, Gough NM, Begley CG, Metcalf D, Nicola NA, Willson TA: Cloning of a murine IL-11 receptor alpha-chain: Requirement for gp130 for high affinity binding and signal transduction. EMBO J 13:4765, 1994
60. Panayotatos N, Everdeen D, Liten A, Somogyi R, Acheson A: Recombinant human CNTF receptor alpha: Production, binding stoichiometry, and characterization of its activity as a diffusible factor. Biochemistry 33:5813, 1994
61. Cherel M, Sorel M, Lebeau B, Dubois S, Moreau J-F, Bataille R, Minvielle S, Jacques Y: Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11. Blood 86:2534, 1995
62. Duquesnoy P, Sobrier M-L, Duriez B, Dastot F, Buchanan CR, Savage MO, Preece MA, Craescu CT, Blouquit Y, Goosens M, Amselem S: A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrom) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J 13:1386, 1994
63. Goddard AD, Covello R, Luoh S-M, Clackson T, Attie KM, Gesundheit N, Rundle AC, Wells JA, Carlsson LMS: Mutations in the growth hormone receptor in children with idiopathic short stature. N Engl J Med 333:1093, 1995
64. Takahashi Y, Haji H, Okimura Y, Goji K, Abe H, Chihara K: Brief report: Short stature caused by a mutant growth hormone. N Engl J Med 334:432, 1996
65. D'andrea R, Rayner J, Moretti P, Lopez A, Goodel GJ, Gonda TJ, Vadas M: A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony stimulating factor, and for IL-5 that leads to ligand independance and tumerogenicity. Blood 83:2802, 1994
66. Warren SA, Metcalf D, Dunn AR: Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 14:5569, 1995
67. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA: Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677, 1992
68. Nielsen K, Hill JM, Anderson MA, Craik DJ: Synthesis and structure determination by NMR of a putative vacuolar targeting peptide and model of a proteinase inhibitor from Nicotiana alata. Biochemistry 35:373, 1996
69. Suzuki H, Yasukawa K, Saito T, Goitsuka R, Hasegawa A, Oshugi Y, Taga T, Kishimoto T: Anti-interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol 22:1989, 1992
70. Wijdenes J, Racadot E, Wendling D: Interleukin-6 antibodies in rheumatoid arthritis. J Int Res 14:297, 1994
71. Montero-Julian FA, Klein B, Gautherot E, Brailly H: Pharma-cokinetic study of anti-interleukin-6 (IL-6) therapy with monoclonal antibodies: Enhancement of IL-6 clearance by cocktails of anti-IL-6 antibodies. Blood 85:917, 1995
72. Panayotatos N, Radziejewska E, Acheson A, Somogyi R, Thadani A, Hendrickson WA, Mcdonald NQ: Localization of functional receptor epitopes on the structure of ciliary neurotrophic factor indicates a conserved, function-related epitope topography among helical cytokines. J Biol Chem 270:14007, 1995